MedTrace Logo

MAKO Total Knee Artroplasty

NCT05744895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123

Last updated 2026-02-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the early clinical and radiographic outcomes of robotically assisted total knee arthroplasty with the MAKO surgical robot using the Triathlon knee system. Results of this study will be compared to those of a previously published cohort of patients from this institution who underwent TKA using non-robotic, manual instruments.

MAKO TKA patients will be given Fitbits and the Focus Motion Knee Brace to capture the data listed in attachment section. The results of this data will be compared to the control group to see if there is or there is not a difference in clinical outcomes with patients receiving Total knee surgery using the MAKO surgical robot versus those who got Total knee surgery without the MAKO robot.

Conditions

  • Osteoarthritis, Knee

Interventions

DEVICE

Device: Robotic MAKO total knee

Prospective TKA patient receiving total knee arthroplasty using the MAKO robotic machine

DEVICE

FocusMotion knee brace

Focusmotion knee brace measures range of motion during exercises

DEVICE

Fitbit tracking device

Fitbit will measure patients steps, HR, and sleep

DEVICE

FocusMotion app

Will survey patients with PROMS

Sponsors & Collaborators

  • Stryker Nordic

    collaborator INDUSTRY

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Charles Hannon, MD · Washington University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-14
Primary Completion
2025-06-30
Completion
2025-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05744895 on ClinicalTrials.gov